Intestinal Colonized Silkworm Chrysalis‐Like Probiotic Composites for Multi‐Crossed Comprehensive Synergistic Therapy of Inflammatory Bowel Disease

Abstract Inspired by the timely emergence of silkworm pupae from their cocoons, silkworm chrysalis‐like probiotic composites (SCPCs) are developed for the comprehensive therapy of inflammatory bowel disease (IBD), in which probiotics are enveloped as the “pupa” in a sequential layering of silk sericin (SS), tannic acid (TA), and polydopamine, akin to the protective “cocoon”. Compared to unwrapped probiotics, these composites not only demonstrate exceptional resistance to the harsh gastrointestinal environment and exhibit over 200 times greater intestinal colonization but also safeguard probiotics from the damage of IBD environment while enabling probiotics sustained release. The probiotics, in synergy with SS and TA, provide a multi‐crossed comprehensive therapy for IBD that simultaneously addresses various pathological features of IBD, including intestinal barrier disruption, elevated pro‐inflammatory cytokines, heightened oxidative stress, and disturbances in the intestinal microbiota. SCPCs exhibit remarkable outcomes, including a 9.7‐fold reduction in intestinal permeability, an 8.9‐fold decrease in IL‐6 levels, and a 2.9‐fold reduction in TNF‐α levels compared to uncoated probiotics. Furthermore, SCPCs demonstrate an impressive 92.25% reactive oxygen species clearance rate, significantly enhance the richness of beneficial intestinal probiotics, and effectively diminish the abundance of pathogenic bacteria, indicating a substantial improvement in the overall therapeutic effect of IBD.